These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34236515)

  • 1. Hidden brain iron content in sickle cell disease: impact on neurocognitive functions.
    Elalfy MS; Ibrahim AS; Ibrahim GS; Hussein HMAG; Mohammed HGE; Ebeid FSE
    Eur J Pediatr; 2021 Aug; 180(8):2677-2686. PubMed ID: 34236515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statural Growth and Prevalence of Endocrinopathies in Relation to Liver Iron Content (LIC) in Adult Patients with Beta Thalassemia Major (BTM) and Sickle Cell Disease (SCD).
    Yassin MA; Soliman AT; De Sanctis V; Abdula MAJ; Riaz LM; Ghori FF; Yousaf A; Nashwan AJ; Abusamaan S; Moustafa A; Kohla S; Soliman DS
    Acta Biomed; 2018 Feb; 89(2-S):33-40. PubMed ID: 29451227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain iron content in systemic iron overload: A beta-thalassemia quantitative MRI study.
    Manara R; Ponticorvo S; Tartaglione I; Femina G; Elefante A; Russo C; Carafa PA; Cirillo M; Casale M; Ciancio A; Di Concilio R; De Michele E; Weiskopf N; Di Salle F; Perrotta S; Esposito F
    Neuroimage Clin; 2019; 24():102058. PubMed ID: 31711032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing cardiac and liver iron overload in chronically transfused patients with sickle cell disease.
    Badawy SM; Liem RI; Rigsby CK; Labotka RJ; DeFreitas RA; Thompson AA
    Br J Haematol; 2016 Nov; 175(4):705-713. PubMed ID: 27507431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spleen R2 and R2* in iron-overloaded patients with sickle cell disease and thalassemia major.
    Brewer CJ; Coates TD; Wood JC
    J Magn Reson Imaging; 2009 Feb; 29(2):357-64. PubMed ID: 19161188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance detection of kidney iron deposition in sickle cell disease: a marker of chronic hemolysis.
    Schein A; Enriquez C; Coates TD; Wood JC
    J Magn Reson Imaging; 2008 Sep; 28(3):698-704. PubMed ID: 18777554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease.
    Voskaridou E; Douskou M; Terpos E; Papassotiriou I; Stamoulakatou A; Ourailidis A; Loutradi A; Loukopoulos D
    Br J Haematol; 2004 Sep; 126(5):736-42. PubMed ID: 15327528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of liver iron accumulation in patients with sickle cell disease and thalassemia with iron overload.
    Hankins JS; Smeltzer MP; McCarville MB; Aygun B; Hillenbrand CM; Ware RE; Onciu M
    Eur J Haematol; 2010 Jul; 85(1):51-7. PubMed ID: 20374273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationships between pancreatic T2* values and pancreatic iron loading with cardiac dysfunctions,  hepatic and cardiac iron siderosis among Egyptian children and young adults with β-thalassaemia major and sickle cell disease: a cross-sectional study.
    Salama K; Abdelsalam A; Eldin HS; Youness E; Selim Y; Salama C; Hassanein G; Samir M; Zekri H
    F1000Res; 2020; 9():1108. PubMed ID: 34249348
    [No Abstract]   [Full Text] [Related]  

  • 10. Quantitative T2* magnetic resonance imaging for evaluation of iron deposition in the brain of β-thalassemia patients.
    Akhlaghpoor S; Ghahari A; Morteza A; Khalilzadeh O; Shakourirad A; Alinaghizadeh MR
    Clin Neuroradiol; 2012 Sep; 22(3):211-7. PubMed ID: 22159731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of cardiac siderosis by MRI T2* despite transfusion burden, hepatic and serum iron overload in Lebanese patients with sickle cell disease.
    Inati A; Musallam KM; Wood JC; Sheikh-Taha M; Daou L; Taher AT
    Eur J Haematol; 2009 Dec; 83(6):565-71. PubMed ID: 19737308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron Overload in Patients With Heavily Transfused Sickle Cell Disease-Correlation of Serum Ferritin With Cardiac T2
    Alkindi S; Panjwani V; Al-Rahbi S; Al-Saidi K; Pathare AV
    Front Med (Lausanne); 2021; 8():731102. PubMed ID: 34760898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.
    Koren A; Fink D; Admoni O; Tennenbaum-Rakover Y; Levin C
    Eur J Haematol; 2010 Jan; 84(1):72-8. PubMed ID: 19732137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pituitary Volume and Iron Overload Evaluation by 3T MRI in Thalassemia.
    Nayak AM; Choudhari A; Patkar DP; Merchant RH
    Indian J Pediatr; 2021 Jul; 88(7):656-662. PubMed ID: 33675027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfusional Iron Overload in a Cohort of Children with Sickle Cell Disease: Impact of Magnetic Resonance Imaging, Transfusion Method, and Chelation.
    Stanley HM; Friedman DF; Webb J; Kwiatkowski JL
    Pediatr Blood Cancer; 2016 Aug; 63(8):1414-8. PubMed ID: 27100139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deferiprone as an oral iron chelator in sickle cell disease.
    Voskaridou E; Douskou M; Terpos E; Stamoulakatou A; Meletis J; Ourailidis A; Papassotiriou I; Loukopoulos D
    Ann Hematol; 2005 Jul; 84(7):434-40. PubMed ID: 15809885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency, pattern, and associations of renal iron accumulation in sickle/β-thalassemia patients.
    Meloni A; Barbuto L; Pistoia L; Positano V; Renne S; Peritore G; Fina P; Spasiano A; Allò M; Messina G; Casini T; Massa A; Romano L; Pepe A; Cademartiri F
    Ann Hematol; 2022 Sep; 101(9):1941-1950. PubMed ID: 35821343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronically transfused pediatric sickle cell patients are protected from cardiac iron overload.
    Kaushik N; Eckrich MJ; Parra D; Yang E
    Pediatr Hematol Oncol; 2012 Apr; 29(3):254-60. PubMed ID: 22303979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Tissue Elastography With Magnetic Resonance Imaging T2* and Serum Ferritin Quantification in Detecting Liver Iron Overload in Patients With Thalassemia Major.
    Pipaliya N; Solanke D; Parikh P; Ingle M; Sharma R; Sharma S; Sawant P
    Clin Gastroenterol Hepatol; 2017 Feb; 15(2):292-298.e1. PubMed ID: 27650324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of biventricular dimensions and function between pediatric sickle-cell disease and thalassemia major patients without cardiac iron.
    Meloni A; Detterich J; Berdoukas V; Pepe A; Lombardi M; Coates TD; Wood JC
    Am J Hematol; 2013 Mar; 88(3):213-8. PubMed ID: 23386313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.